Also trades as: 0J2O.L (LSE) · $vol 0M
HALO Smart Money
Halozyme Therapeutics, Inc.
1W: +3.3%
1M: +13.8%
3M: +54.3%
YTD: +82.8%
1Y: +94.3%
3Y: +265.5%
5Y: +231.5%
$128.50
+0.49 (+0.38%)
Weekly Expected Move ±4.8%
$114
$120
$126
$132
$138
Credit Risk of going bust: lower than 70% of companies Debt: 12.8% of company value Bonds: $229.7M held by 80 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.59 (down 99%), Halozyme Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.15B against a stock market value of $14.58B.
Distance to default 7.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.18B (short-term plus half of long-term), stock volatility 36.4%; Altman Z'' 3.33. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.59 (down 99%), Halozyme Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.15B against a stock market value of $14.58B.
Distance to default 7.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.18B (short-term plus half of long-term), stock volatility 36.4%; Altman Z'' 3.33. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026739
Institutions Holding
+36 vs prior
65.3%
Ownership
+12.14%
108
New
270
Increased
272
Reduced
65
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Torley Helen | officer: president and ceo | S-Sale | 200 | $110.51 | $22K | Filing |
| 2026-10-08 | Torley Helen | officer: president and ceo | S-Sale | 11,900 | $110.00 | $1.3M | Filing |
| 2026-10-08 | Torley Helen | officer: president and ceo | S-Sale | 3,090 | $108.91 | $337K | Filing |
| 2026-10-08 | Torley Helen | officer: president and ceo | S-Sale | 4,810 | $108.18 | $520K | Filing |
| 2026-10-07 | Torley Helen | officer: president and ceo | S-Sale | 200 | $113.69 | $23K | Filing |
| 2026-10-07 | Torley Helen | officer: president and ceo | S-Sale | 900 | $112.78 | $102K | Filing |
| 2026-10-07 | Torley Helen | officer: president and ceo | S-Sale | 10,300 | $111.84 | $1.2M | Filing |
| 2026-10-07 | Torley Helen | officer: president and ceo | S-Sale | 8,600 | $111.03 | $955K | Filing |
| 2026-10-06 | Torley Helen | officer: president and ceo | S-Sale | 1,780 | $110.81 | $197K | Filing |
| 2026-10-06 | Torley Helen | officer: president and ceo | S-Sale | 9,920 | $109.89 | $1.1M | Filing |
| 2026-10-06 | Torley Helen | officer: president and ceo | S-Sale | 6,000 | $109.33 | $656K | Filing |
| 2026-10-06 | Torley Helen | officer: president and ceo | S-Sale | 2,300 | $107.90 | $248K | Filing |
| 2026-10-01 | Posard Matthew L. | director | S-Sale | 100 | $110.04 | $11K | Filing |
| 2026-10-01 | Posard Matthew L. | director | S-Sale | 1,100 | $109.57 | $121K | Filing |
| 2026-10-01 | Posard Matthew L. | director | S-Sale | 3,300 | $108.45 | $358K | Filing |
| 2026-10-01 | Posard Matthew L. | director | S-Sale | 730 | $107.17 | $78K | Filing |
| 2026-10-01 | Daly James M | director | A-Grant/Award | 1,169 | $— | $0 | Filing |
| 2026-09-16 | Posard Matthew L. | director | S-Sale | 4,000 | $108.99 | $436K | Filing |
| 2026-09-16 | Posard Matthew L. | director | S-Sale | 8,896 | $108.04 | $961K | Filing |
| 2026-09-16 | Posard Matthew L. | director | S-Sale | 3,000 | $106.83 | $320K | Filing |
| 2026-09-16 | Posard Matthew L. | director | S-Sale | 3,100 | $106.13 | $329K | Filing |
| 2026-09-11 | Torley Helen | officer: president and ceo | S-Sale | 15,492 | $107.15 | $1.7M | Filing |
| 2026-09-11 | Torley Helen | officer: president and ceo | S-Sale | 4,508 | $107.55 | $485K | Filing |
| 2026-09-10 | Torley Helen | officer: president and ceo | S-Sale | 5,412 | $107.58 | $582K | Filing |
| 2026-09-10 | Torley Helen | officer: president and ceo | S-Sale | 14,588 | $107.01 | $1.6M | Filing |
🏛️ Congressional Trades
16 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2026-09-29 | Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Filing |
| 2026-09-29 | Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Filing |
| 2026-03-09 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2026-03-08 | Gilbert Ray Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2025-03-24 | Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Filing |
| 2025-03-23 | Gilbert Ray Cisneros | House | Sell | $1,001 - $15,000 | Filing |
| 2024-09-09 | Josh Gottheimer | House | Sell | $1,001 - $15,000 | Filing |
| 2023-07-12 | Daniel Goldman | House | Sell | $15,001 - $50,000 | Filing |
| 2022-12-06 | Josh Gottheimer | House | Sell | $1,001 - $15,000 | Filing |
| 2022-08-05 | Josh Gottheimer | House | Sell | $1,001 - $15,000 | Filing |
| 2021-08-20 | Josh Gottheimer | House | Buy | $1,001 - $15,000 | Filing |
| 2020-10-22 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2020-10-19 | Josh Gottheimer | House | Buy | $1,001 - $15,000 | Filing |
| 2017-11-06 | Mark Warner | Senate | Sell | $500,001 - $1,000,000 | Filing |
| 2017-11-06 | Mark Warner | Senate | Sell | $500,001 - $1,000,000 | Filing |
| 2017-11-06 | Mark R. Warner | Senate | Sell | $500,001 - $1,000,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,271,095 | $1.0B | +6,042 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,351,312 | $419M | +80,094 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,299,008 | $415M | +49,802 | 2026-06-30 | Filing |
| STATE STREET CORP | 5,179,434 | $405M | +241,580 | 2026-06-30 | Filing |
| Invesco Ltd. | 3,177,997 | $249M | -834,497 | 2026-06-30 | Filing |
| MORGAN STANLEY | 2,832,594 | $222M | +270,285 | 2026-06-30 | Filing |
| Boston Partners | 2,773,568 | $217M | +89,885 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 2,740,561 | $215M | -172,548 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,519,951 | $197M | +14,165 | 2026-06-30 | Filing |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2,511,050 | $197M | -14,925 | 2026-06-30 | Filing |
| SNYDER CAPITAL MANAGEMENT L P | 2,396,101 | $188M | +73,024 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 2,089,567 | $164M | +9,740 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 2,006,479 | $157M | +137,771 | 2026-06-30 | Filing |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1,938,035 | $152M | +1,248,120 | 2026-06-30 | Filing |
| ROYAL LONDON ASSET MANAGEMENT LTD | 1,810,815 | $142M | +200,262 | 2026-06-30 | Filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,704,623 | $133M | -213,526 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 1,653,285 | $129M | +68,324 | 2026-06-30 | Filing |
| UBS Group AG | 1,492,224 | $117M | +578,221 | 2026-06-30 | Filing |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1,491,004 | $117M | +25,721 | 2026-06-30 | Filing |
| NORGES BANK | 1,483,648 | $116M | +1,483,648 | 2026-06-30 | Filing |